Printer Friendly
The Free Library
5,670,285 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Matrix Scientific Group Inc. to Unveil Stem Cell Extraction Devices at the American Association of Tissue Banks.


SAN DIEGO San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay.  -- Bio-Matrix Scientific Group Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:BMSN BMSN Seaman, Boatswain's Mate Striker (Naval Rating) ), a biotechnology company focused on stem cell stem cell

In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult.
 cryogenics cryogenics: see low-temperature physics.
cryogenics

Study and use of low-temperature phenomena. The cryogenic temperature range is from −238°F (−150°C) to absolute zero. At low temperatures, matter has unusual properties.
 and disposable stem cell / tissue transfer instruments, announced today that it will unveil its new stem cell extraction kits at the American Association of Tissue Banks.

Brian Pockett, Managing Director and COO, stated, "We feel that this is an excellent opportunity to introduce our stem cell extraction kits to physicians and specialists in the tissue banking industry."

The American Association of Tissue Banks 30th Annual Meeting in San Diego, CA, September 9-12, 2006, is designed for physicians who are medical directors or pathologists; those physician specialists (e.g., orthopedic surgeons, burn surgeons) who rely on the use of tissue in patient care and treatment; tissue bank specialists; quality assurance staff; and all others involved in tissue banking.

About Bio-Matrix Scientific Group Inc.

Bio-Matrix Scientific Group Inc. (www.BMSNonline.com), is a biotech research and development Company that commercializes medical devices and monitoring systems for the growing, worldwide stem cell research market.

The Company aligns itself with strategic partners that offer key technologies in biomedical bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
 device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation and is building a state-of-the-art facility in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation).
San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951.
, to cater to the growing stem cell research segment of the $75 billion biotechnology and medical device industry.

DISCLAIMER: This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 6, 2006
Words:303
Previous Article:July Systems Issued Patent for Real-Time Personalization of Mobile Content Services; Technology Stimulates Mobile Content Sales With User-Aware...
Next Article:Inovio's Electroporation Patent Estate Expanded with the Allowance of Claims in Europe.
Topics:



Related Articles
Biotech Company sees fat profits with stem cell harvest.(StemSource Inc. extracts stem cells from human fat)(Brief Article)(Company Profile)
Bio-Matrix Announces Contract with Emergo Group Inc. for FDA cGMP/cGTP Compliance and ISO 13485:2003 Certification.
Self help: stem cells rescue lupus patients.(This Week)
Bio-Matrix Files US and International Utility Patents on Its Stem Cell Extraction Medical Devices.
Bio-Matrix Announces the Completion of Its Medical Device Engineering, Testing and Research Laboratory.
Bio-Matrix Scientific Group Inc. Starts Final Phase of Class 10,000 Processing Laboratory Installation.
Bio-Matrix Scientific Group Inc. Update on Class 10,000 Stem Cell Banking and Cellular Tissue Processing Laboratories.
Bio-Matrix Scientific Group Inc. Processing Laboratory Nearing Completion.
Bio-Matrix Announces Construction and Installation of the Class 10,000 Stem Cell Cellular Tissue Processing Laboratory Completed.
Bio-Matrix Scientific Receives Certificate of Compliance for Class 10,000 Processing Laboratory.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles